Edesa Biotech, Inc. — Director's Dealing 2020

Oct 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edesa Biotech, Inc. (EDSA)
CIK: 0001540159
Period of Report: 2020-10-13

Reporting Person: Pay Paul William (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-13	Stock option (right to buy)	$7.44	A	20000	Acquired	2030-10-13	Common shares (20000)	Direct

Footnotes

F1: This option vests monthly in equal proportions over 36 months beginning on the Grant Date.